Home - Products - Others - Other Targets - Folinic Acid Calcium Salt Pentahydrate

Folinic Acid Calcium Salt Pentahydrate

CAS No. 6035-45-6

Folinic Acid Calcium Salt Pentahydrate ( —— )

Catalog No. M15258 CAS No. 6035-45-6

Folinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
500MG 76 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Folinic Acid Calcium Salt Pentahydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Folinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.
  • Description
    Folinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.(In Vitro):MTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) .(In Vivo):Folinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice).
  • In Vitro
    MTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) .
  • In Vivo
    Folinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice). Animal Model:24 Balb/c young growing male mice aged 3 weeks (11.88 ± 0.25 g) Dosage:7.0 mg/kg Administration:Intraperitoneal injection; every second day; for 3 weeks Result:Following methotrexate (MTX) administration appears to reverse this growth inhibition.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Folate Analogue
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    6035-45-6
  • Formula Weight
    601.58
  • Molecular Formula
    C20H21CaN7O7·5H2O
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 40 mg/mL warmed (66.49 mM)
  • SMILES
    NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N2C=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Van der Wilt CL, et al. Y Res, 1992, 52(18), 4922-4928.
molnova catalog
related products
  • Urantide

    Selective and competitive urotensin-II (UT) receptor antagonist (pKB = 8.3). Blocks hU-II induced contractions in thoracic aorta ex vivo. Exhibits no effect on noradrenaline or endothelin 1-induced contraction or on acetylcholine-induced relaxation. Behaves as a partial agonist in a calcium mobilization assay (in CHO cells expressing hUT receptors).

  • BNP-45 (rat) (TFA) (...

    BNP-45 (rat) TFA is a circulating form of rat brain natriuretic peptide isolated from rat heart with potent hypotensive and natriuretic potency.

  • sun

    SUN is an orally active and potent inhibitor of DAAO (DAO).